一种工程原药在混合微生物环境中选择性地抑制β-乳酸盐耐药细菌
Addison M Duda1, Helena R Ma2, César A Villalobos2
1Department of Chemistry, Duke University, Durham, North Carolina 27708, United States.
ACS infectious diseases
|June 12, 2025
概括
新的前药AcephPT针对具有扩展光谱β-乳酸酶 (ESBLs) 的细菌. 这一策略选择性地抑制了耐药菌株,为打击抗生素耐药性和促进抗菌药物管理提供了一种新的方法.
科学领域:
- 微生物学 微生物学
- 药用化学 医学化学
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 越来越多的抗生素耐药性,特别是β-乳糖耐药性,对公众健康构成重大威胁.
- 扩展光谱β-乳酸酶 (ESBLs) 是关键酶,在格拉姆阴性细菌中赋予对许多β-乳酸抗生素的耐药性.
研究的目的:
- 设计一种新型β-乳前药物AcephPT,旨在通过ESBL选择性激活.
- 证明AcephPT可以选择性地抑制产生ESBL的细菌,同时不影响易受感染的细菌.
主要方法:
- 设计和合成β-乳前药AcephPT.
- 在克隆种群和含有ESBL生产和非生产细菌的混合微生物培养中测试AcephPT活性.
- 使用时间过程核磁共振 (NMR) 光谱来确认前药物激活.
主要成果:
- 在AcephPT的研究中,AcephPT被证明可以选择性地抑制产生ESBL的格拉姆阴性细菌.
- 对表达ESBLs的实验室菌株和临床隔离物均观察到有效的选择性.
- 核磁共振实验证实,AcephPT的水解活性仅由产生ESBL的细菌引起.
结论:
- AcephPT可以选择性地向并抑制ESBL产生的细菌.
- 这种方法提供了一种潜在的策略,可以对抗β-乳酸盐耐药性,同时保持抗生素的疗效,并支持抗菌药物管理.
更多相关视频
08:06The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
9.0K
05:06Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System
Published on: January 5, 2024
549
相关概念视频
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Antibiotic Selection
52.4K
Overview
52.4K
Prodrugs
2.5K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.5K
